Background. Resource-constrained countries have difficulty conducting large EQ-5D valuation studies, which limits their ability to conduct cost-utility analyses using a value set specific to their own population. When estimates of similar but related parameters are available, shrinkage estimators reduce uncertainty and yield estimators with smaller mean square error (MSE). We hypothesized that health utilities based on shrinkage estimators can reduce MSE and mean absolute error (MAE) when compared to country-specific health utilities. Methods. We conducted a simulation study (1,000 iterations) based on the observed means and standard deviations (or standard errors) of the EQ-5D-3L valuation studies from 14 counties. In each iteration, the simulated data were fitted with the model based on the country-specific functional form of the scoring algorithm to create country-specific health utilities (''naı¨ve'' estimators). Shrinkage estimators were calculated based on the empirical Bayes estimation methods. The performance of shrinkage estimators was compared with those of the naı¨ve estimators over a range of different sample sizes based on MSE, MAE, mean bias, standard errors and the width of confidence intervals. Results. The MSE of the shrinkage estimators was smaller than the MSE of the naı¨ve estimators on average, as theoretically predicted. Importantly, the MAE of the shrinkage estimators was also smaller than the MAE of the naı¨ve estimators on average. In addition, the reduction in MSE with the use of shrinkage estimators did not substantially increase bias. The degree of reduction in uncertainty by shrinkage estimators is most apparent in valuation studies with small sample size. Conclusion. Health utilities derived from shrinkage estimation allow valuation studies with small sample size to ''borrow strength'' from other valuation studies to reduce uncertainty.
were derived from small-sized valuation studies may find themselves having more uncertainty in their QALY estimates in their economic evaluations. Thus, resourceconstrained countries may struggle to obtain sufficiently precise estimates from cost-utility analyses.
Theoretically, one method to improve the precision of EQ-5D value sets is shrinkage estimation. Shrinkage estimators have been mathematically shown to reduce mean square errors. 8, 9 Therefore, this method may allow resource-limited countries to conduct their own EQ-5D valuation studies with smaller sample sizes and borrow strength from other countries to shrink the uncertainty (i.e., SEs) of their predicted mean utility estimates. [9] [10] [11] Shrinkage estimators have previously been applied to mean cost estimates in the setting of multinational costeffectiveness analysis. 10 Therefore, we hypothesized that shrinkage estimators could help reduce uncertainty of value sets in situations where sample sizes are small. We used simulation methods to investigate whether shrinkage estimators allowed resource-limited countries to develop their own value sets using a relatively small valuation study (\300 respondents), while still achieving a reasonable mean square error (MSE). Furthermore, we hypothesized that mean absolute error (MAE) may also be reduced with shrinkage estimators.
The rest of the paper is organised as follows. First, we provide the rationale and motivation for considering the use of shrinkage estimators for EQ-5D value sets. Second, we discuss the theoretical beneficial properties of shrinkage estimators. Third, we describe the setup of the simulation to evaluate the performance of shrinkage estimators. Fourth, we present the performance of the shrinkage estimators compared with the traditional country-specific estimators from the valuation study. Last, we provide suggestions about when shrinkage estimators are most helpful.
Methods

What Is Shrinkage Estimation?
Shrinkage estimators work by assuming that the true health utilities of each country are drawn from a common distribution. The country-specific shrinkage estimates are calculated by their posterior means given the data from the health utilities of all the countries. Therefore, shrinkage estimation borrows strength from across the countries, and has been mathematically shown to result in a smaller mean square error (MSE) than the estimator derived using country-specific data alone. 9 The amount of shrinkage depends on both the between-country variability (i.e., variation across countries) and sampling variation in the country-specific estimate. Therefore, the smaller the sample size of the valuation study of the country, the more within-country variance there will be (i.e., larger SE of the health states), and the larger the amount of shrinkage. That is, countries in which the evidence to inform the estimates of the utilities of the health states is weak due to small sample sizes will borrow more strength from other countries.
Shrinkage estimators are also known as Empirical Bayes estimators 12 because the data are used to specify the prior instead of using subjective estimates or previous evidence to specify the prior. An advantage of the Empirical Bayes approach over a fully Bayesian approach is that the former is less sensitive to the prior distribution for the between-country variance. It is well established that the choice of vague prior can be highly influential on the results when the number of studies (i.e., countries with valuation studies) is relatively small. 13 The Empirical Bayes approach avoids this issue by estimating the unknown parameters using frequentist methods.
Why Consider Shrinkage Estimator in the Context of the EQ-5D?
In statistical estimation, there is usually a bias-variance trade-off. This means that it may be possible to obtain a more precise estimator (i.e., an estimator with a smaller variance) if one is willing to tolerate some increase in bias. In the context of creating EQ-5D value sets, this trade-off is very appealing. This is because a valuation study is typically performed only once per country. Because it is only done once, it is the deviation of the predicted utility estimates for each health state from the truth that matters, and it makes no difference whether the deviation is because of bias or sampling variation. Therefore, in the context of EQ-5D value sets, we do not need to be concerned about trading off bias for variance provided that the estimated utilities are closer to the truth.
This deviation from the truth is usually measured by the mean square error (MSE), which is the expected value of the square of the difference between estimated and true utilities. It is well known that the MSE is equal to the sum of the square of the bias and the variance. Since shrinkage estimators have been mathematically shown to reduce MSE, 14 it is appealing to consider using shrinkage estimators to reduce MSE of the utilities in the EQ-5D value sets.
Construction of the Simulation Study
We constructed a simulation to examine the properties of shrinkage estimators on EQ-5D-3L-derived health utilities.
The input parameters of the simulation were based on published literature. First, we performed a literature search to identify all EQ-5D-3L valuation studies. We reviewed the published manuscripts and the appendices to identify valuation studies that stated explicitly which EQ-5D-3L health states were directly valued and that reported the observed mean utilities and their standard deviations (SD; or SE and the number of respondents) for each of the health states directly valued. We included only valuation studies that also explicitly described the functional form of their final model.
The simulation model was designed to generate 1,000 simulated datasets (i.e., 1,000 iterations) for each included valuation study. Each simulated dataset was created so that each respondent evaluated the same number of health states as in the original country-specific valuation study. For each health state in each country, the distribution of the valuations among respondents was characterized as a multivariate normal distribution, with means given by the observed mean valuations for the health states in question, variance-covariance matrix characterized by an exchangeable correlation structure with correlation 0.406, 15 and variances given by the squares of the reported SD of the observed health states. The technical details of the simulation are described in Appendix A.
Regression models were fitted for each simulated dataset in each country using the same functional form as in the original publication, and estimating parameters using a random effects model with respondent-level random intercepts (for technical details, see Appendix A). The regression coefficients were then used to calculate the predicted EQ-5D-3L value sets for the 243 health states in each iteration for each country. These estimators of utility will be referred to as country-specific ''naı¨ve estimators'' and predicted utility estimates (value sets) are referred to as country-specific ''naı¨ve estimates''.
In each iteration, the naı¨ve estimates of health utilities and their corresponding SEs from each country for each of the 243 health states were used to calculate the shrinkage estimates of health utilities (and their SE) for each country. (The technical details of the calculation of the shrinkage estimator and its variance can be found in Appendix A).
Comparing Shrinkage Estimators and Naıve Estimators
We calculated the bias of the estimators (either naı¨ve estimator or shrinkage estimator) by subtracting the mean utility for each health state used to simulate the data from the estimated utility. The mean error for each health state was then calculated by taking the mean across all simulations for that health state for the specific country. The mean error of the estimators for the country was then calculated by taking the mean across all health states that were directly valued for the specific country. We also calculated the mean absolute error (MAE), the mean squared error (MSE), and the root mean squared error (RMSE).
We then examined the impact of a smaller sample size on the comparisons between shrinkage estimators and naı¨ve estimators. Specifically, for each country, we evaluated sample sizes of 50, 100, 150, 200, 250, and 300 to examine the performance of the naı¨ve estimators and the shrinkage estimators with respect to MSE and MAE, while holding the sample size of the remaining countries fixed. We also examined the SE and the width of the 95% confidence interval of health utilities of the naı¨ve estimators and shrinkage estimators.
Results
Our literature search identified 14 valuation studies 7, [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] that reported the mean observed health utilities and their SD (or SE), see Table 1 .
The extracted mean observed health utilities and their SD (or SE) are shown in Appendix B. The sample size of the valuation studies ranges from 298 (Netherlands) to 3,773 (US). The results for the MSE and MAE are shown in Tables 2 and 3 (The result for RMSE is shown in Appendix C). Shrinkage estimators reduced MSE on average as expected according to theory (see Table 2 and Appendices D and E), most noticeably for small sample size. The MAE is also reduced on average (see Table 3 and Appendices F and G). The degree of bias of shrinkage estimators appears small (see Table 4 ). The relationships between sample size and the probability of predicted MAE or MSE falling below different specific MAE and MSE thresholds are shown in Appendices H to K. Generally, for a given sample size, the probabilities of predicted MAE/MSE falling below a specific threshold increase with the use of shrinkage estimators when compared with the naı¨ve estimators.
Discussion
Our analysis confirmed the feasibility of computing country-specific shrinkage estimators of value sets of MAUI-derived health utilities. These shrinkage estimators have the desirable property of reducing MSE as expected based on mathematical theories. 14 In addition, our simulation also supported the hypothesis that shrinkage estimators reduced MAE (mean deviation) when compared with naive estimators. The reduction in MSE and MAE were more substantial with smaller sample sizes, as expected.
The use of shrinkage estimators can enable resourceconstrained countries with more challenging research funding environments to conduct valuation studies to come up with their own country-specific value sets with slightly smaller sample sizes while still achieving reasonable MSE and MAE. This is particularly important because these are typically the same countries that face challenges in prioritizing and allocating scarce health care resources. They will need to have their own country-specific value sets to conduct cost-effectiveness analysis to aid decision making that reflects their own public values.
Based on our results, while shrinkage estimators reduced MSE on average, as expected by theory, the magnitude of the reduction is relatively small (or, in rare cases, even a reverse direction). This is because the variation in value sets across the countries (i.e., betweencountry variation) was large compared with the sampling variation within each country (i.e., within-country variation) for EQ-5D-3L overall. Generally, the MSE of valuation studies depends on sample size and the degree of mis-specification of the scoring algorithm. MSE decreases with increasing sample size up to a point, beyond which a further increase in sample size does not lead to a further reduction in MSE, as the remaining MSE is related to the mis-specification of the scoring algorithm rather than sampling variation. With the use of a common protocol with EQ-5D-5L, it is possible that we may observe less between-country variation relative to the within-country variation with EQ-5D-5L value sets, making the use of shrinkage estimators more attractive in countries with smaller valuation study.
There is no universal consensus of what is an acceptable level of MSE or MAE for MAUI scoring algorithms. For example, a recent study suggested that the MAE of EQ-5D scoring algorithms ranged from 0.024 to 0.090, while the MSE ranged from 0.0009 to 0.0784, 29 with larger countries having smaller MAE and MSE. Our findings suggest that shrinkage estimators help reduce MAE by about 0.005 and MSE by 0.0001 on average when the sample size is small. To the best of our knowledge, this is the first evaluation of the use of shrinkage estimators in health utility estimation. The use of shrinkage estimators has previously been examined in the estimation of mean costs in multinational cost-effectiveness analyses. 10, 11 One of the assumptions of this approach is that the mean of each of the health utilities is normally distributed within each country. Previous work has demonstrated that this assumption holds even when patient-level observations are quite skewed, because of the central limit theorem. [30] [31] [32] [33] Another assumption is that the mean utilities for each health state are normally distributed between countries. In previous simulation studies, 10 even when the distribution between countries is uniform, the shrinkage estimators still out-perform the naı¨ve country-specific estimators in most cases based on confidence interval coverage and efficiency. Furthermore, one of the assumptions of the use of shrinkage estimators is the assumption of exchangeability. While this may not be strictly the case given that the societal preference and the functional form of the EQ-5D-3L for each country may differ from others, our simulation study suggests that the shrinkage estimators are performing as expected theoretically.
In this current simulation, most of the countries we used are not considered resource-constrained countries. Notwithstanding, our results should theoretically apply when more resource-constrained countries are included, provided the exchangeability assumption holds true. In our current studies, we were unable to include more resource-constrained countries given their countryspecific SD (or SE) of the observed mean utilities were not reported in the published literature. Ideally, researchers who have access to such data can further evaluate the performance of shrinkage estimators empirically in more resource-constrained countries. On a practical note, there are pros and cons of conducting a smaller valuation study and applying shrinkage analysis v. conducting a full-size valuation study. The obvious benefit of the former is that there will be savings of time and resources, and the magnitude of such savings depends on how many fewer subjects are needed because of the shrinkage, which in turn is related to the degree of reduction of MSE by the shrinkage estimates. It also depends on the size of the valuation study that can be conducted based on the financial constraints of a particular resource-constrained country. The actual conduct of the shrinkage analysis and the computation time are generally trivial when compared to the time and resources needed to conduct a full-size valuation study. Nevertheless, the need to include other countries' value sets to ''borrow'' strength may potentially be viewed by some as having less local relevance, especially in countries where the assumption of exchangeability may be challenged based on face value.
Also, future valuation studies are more likely to be conducted using EQ-5D-5L instead of EQ-5D-3L (i.e., 3,125 health states instead of 243 health states). However, the number of estimated parameters in the scoring algorithm and the number of directly valued health states will not be increased by the same order of magnitude (e.g., The Canadian EQ-5D-5L scoring algorithm has 12 estimated parameters in their model and the valuation study directly observed 86 health states. 34 The within-country (i.e., within-study) variance may become more significant when compared with betweencountry variability. In that setting, shrinkage estimators may become useful even for countries with moderate-to large-size valuation studies. Further work needs to be done to evaluate the performance of shrinkage estimators of health utilities in ED-5D-5L. As all EQ-5D-5L studies will be using a common protocol (unlike EQ-5D-3L), the assumption of exchangeability is even more plausible when applying shrinkage estimation on EQ-5D-5L.
In conclusion, we have demonstrated that shrinkage estimators have desirable properties for EQ-5D-3L-derived health utilities, especially in valuation studies with very low sample size, to help improve precision in the estimated mean health utilities.
Supplementary Material
Supplementary material for this article is available on the Medical Decision Making Web site at http://journals.sagepub .com/home/mdm. 
